Development of a gene transfer-based treatment for radiation-induced salivary hypofunction
Abstract
A significant long-term side effect of radiation therapy for head and neck cancers is xerostomia, a dry mouth, due to salivary gland damage. Despite continuing efforts to eliminate this problem, many patients continue to suffer. This brief review describes our efforts to develop a gene transfer approach, employing the aquaporin-1 cDNA, to treat patients with existing radiation-induced salivary hypofunction. A Phase I/II clinical trial, using a recombinant adenoviral vector to mediate gene transfer, is currently underway.
Keywords: Xerostomia, Radiation, Gene therapy, Aquaporin-1, Adenovirus, Oral cancer
To access this article, please choose from the options below
PII: S1368-8375(09)00916-6
doi:10.1016/j.oraloncology.2009.09.004
Published by Elsevier Inc.
